Physio-Control, a provider of emergency medical response technology for use in the intervention and treatment of cardio-respiratory sudden cardiac arrest and other medical emergencies, has completed the sale of the company to an affiliate of private investment firm Bain Capital.
The transaction, which was announced on 17 November, 2011, was valued at approximately USD487 million. Simultaneous with the closing, Brian Webster, formerly President, has been named Chief Executive Officer of the newly-independent company.
Headquartered in Redmond, Washington, Physio-Control is the global leader in professional emergency response products and services. The company’s professional products include LIFEPAK monitor/defibrillators, the LUCAS 2 chest compression system, and the LIFENET System cloud-based data management tools. Physio-Control also provides a line of automated external defibrillators (AEDs) for emergency use by bystanders in workplace environments, airports, schools and communities. The company was previously owned by Medtronic, Inc. (NYSE:MDT).
“Physio-Control is a market leader at the forefront of emergency response technology, with a well-earned reputation for sophisticated products that emergency responders and medical professionals rely on to save lives,” says Chris Gordon (pictured), a Managing Director at Bain Capital.
